About Bardy Diagnostics
Bardy Diagnostics is a company based in Charlotte (United States) founded in 2013 was acquired by Hillrom in January 2021.. Bardy Diagnostics has raised $83.39 million across 4 funding rounds from investors including Health Enterprise Partners, Square 1 Bank and SV Health Investors. Bardy Diagnostics offers products and services including CAM Patch, BDxCONNECT, and CAM Report. Bardy Diagnostics operates in a competitive market with competitors including iRhythm Tech, Ekso Bionics, Endotronix, Intuition Robotics and Flosonics Medical, among others.
- Headquarter Charlotte, United States
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bardy Diagnostics, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$83.39 M (USD)
in 4 rounds
-
Latest Funding Round
$12.49 M (USD), Series B
Feb 27, 2020
-
Investors
Health Enterprise Partners
& 10 more
-
Employee Count
Employee Count
-
Acquired by
Hillrom
(Jan 19, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bardy Diagnostics
Bardy Diagnostics offers a comprehensive portfolio of products and services, including CAM Patch, BDxCONNECT, and CAM Report. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Lightweight patch for extended cardiac monitoring and accurate P-wave capture.
Cloud platform for uploading and analyzing ECG data from devices.
Generates detailed ECG reports for quick arrhythmia interpretation.
Unlock access to complete
Funding Insights of Bardy Diagnostics
Bardy Diagnostics has successfully raised a total of $83.39M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $12.49 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $12.5M
-
First Round
First Round
(07 Jun 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2020 | Amount | Series B - Bardy Diagnostics | Valuation |
investors |
|
| Jan, 2019 | Amount | Series B - Bardy Diagnostics | Valuation | River Cities Capital | |
| Jul, 2018 | Amount | Series B - Bardy Diagnostics | Valuation | SV Health Investors , Health Enterprise Partners |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bardy Diagnostics
Bardy Diagnostics has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Health Enterprise Partners, Square 1 Bank and SV Health Investors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on early-stage healthcare startups
|
Founded Year | Domain | Location | |
|
Investments are focused on healthcare and information technology sectors.
|
Founded Year | Domain | Location | |
|
Strategic investments in healthcare technologies and data innovations.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bardy Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bardy Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bardy Diagnostics Comparisons
Competitors of Bardy Diagnostics
Bardy Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, Ekso Bionics, Endotronix, Intuition Robotics and Flosonics Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| domain | founded_year | HQ Location |
Exoskeletons for medical rehabilitation and industrial productivity are provided.
|
|
| domain | founded_year | HQ Location |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| domain | founded_year | HQ Location |
AI-based social robots are provided as companions for the elderly.
|
|
| domain | founded_year | HQ Location |
Developer of non-invasive hemodynamic monitoring devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bardy Diagnostics
Frequently Asked Questions about Bardy Diagnostics
When was Bardy Diagnostics founded?
Bardy Diagnostics was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Where is Bardy Diagnostics located?
Bardy Diagnostics is headquartered in Charlotte, United States. It is registered at Charlotte, North Carolina, United States.
Is Bardy Diagnostics a funded company?
Bardy Diagnostics is a funded company, having raised a total of $83.39M across 4 funding rounds to date.
What does Bardy Diagnostics do?
Bardy Diagnostics was founded in 2013 in Charlotte, United States. Operations are centered on the development and marketing of the Carnation Ambulatory Monitor, a P-wave centric device used for ambulatory cardiac monitoring and arrhythmia detection. The monitor is designed to be worn for up to seven days, providing cardiologists with tools for precise diagnosis in the medical device sector.
Who are the top competitors of Bardy Diagnostics?
Bardy Diagnostics's top competitors include iRhythm Tech, Endotronix and Ekso Bionics.
What products or services does Bardy Diagnostics offer?
Bardy Diagnostics offers CAM Patch, BDxCONNECT, and CAM Report.
Who are Bardy Diagnostics's investors?
Bardy Diagnostics has 11 investors. Key investors include Health Enterprise Partners, Square 1 Bank, SV Health Investors, Ascension Ventures, and River Cities Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.